Changzheng Lu

1.2k total citations
14 papers, 564 citations indexed

About

Changzheng Lu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Changzheng Lu has authored 14 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Changzheng Lu's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and interferon and immune responses (2 papers). Changzheng Lu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and interferon and immune responses (2 papers). Changzheng Lu collaborates with scholars based in United States, China and Macao. Changzheng Lu's co-authors include Yang‐Xin Fu, Anli Zhang, Zhenhua Ren, Casey Moore, Guo‐Min Li, Mingyi Chen, Liya Gu, Zhida Liu, Chunbo Dong and Junqiu Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Changzheng Lu

13 papers receiving 559 citations

Peers

Countries citing papers authored by Changzheng Lu

Since Specialization

Citations

This map shows the geographic impact of Changzheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changzheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changzheng Lu more than expected).

Fields of papers citing papers by Changzheng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changzheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changzheng Lu. The network helps show where Changzheng Lu may publish in the future.

Co-authorship network of co-authors of Changzheng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Changzheng Lu. A scholar is included among the top collaborators of Changzheng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changzheng Lu. Changzheng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Coverage and Prior Authorization Policies for Semaglutide and Tirzepatide in Medicare Part D Plans 2025 ·JAMA Network Open ·(unknown), Changzheng Lu, Ya‐Chen Tina Shih, Changchuan Jiang	0
2	Albumin-based co-loaded sonosensitizer and STING agonist nanodelivery system for enhanced sonodynamic and immune combination antitumor therapy 2024 ·Journal of Controlled Release ·(unknown), Lihua Du, (unknown), Zhuoyuan Li, Yu Raymond Shao, (unknown), Chen Wang, Changzheng Lu, (unknown), Haozhe He, Changhua Zhang	11
3	DNAJA2 deficiency activates cGAS-STING pathway via the induction of aberrant mitosis and chromosome instability 2023 ·Nature Communications ·Yaping Huang, Changzheng Lu, Hanzhi Wang, Liya Gu, Yang‐Xin Fu, Guo‐Min Li	13
4	Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity 2022 ·Nature Cancer ·Longchao Liu, Jiahui Chen, Hongyi Zhang, Jianfeng Ye, Casey Moore, Changzheng Lu, Yan Fang, Yang‐Xin Fu, Bo Li	53
5	Precision intervention of cell type-specific targeting is required for future cancer immunotherapy 2022 ·SHILAP Revista de lepidopterología ·(unknown), Anli Zhang, Changzheng Lu	4
6	Dual targeting of CTLA-4 and CD47 on T _reg cells promotes immunity against solid tumors 2021 ·Science Translational Medicine ·Anli Zhang, Zhenhua Ren, Kuo‐Fu Tseng, (unknown), Huiyu Li, Changzheng Lu, (unknown), John D. Minna, Yang‐Xin Fu	64
7	A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response 2020 ·JCI Insight ·Hao‐Dong Li, Changzheng Lu, He Zhang, Qing Hu, Junqiu Zhang, Ileana Cuevas, Subhransu S. Sahoo, Mitzi Aguilar, (unknown), Shanrong Zhang, Xiaojing Wang, Esra A. Akbay, Guo‐Min Li, Bo Li, Prasad Koduru, Peter Ly, Yang‐Xin Fu, Diego H. Castrillón	22
8	Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling 2020 ·Nature Immunology ·Chuanhui Han, Zhida Liu, Yunjia Zhang, Aijun Shen, Chunbo Dong, Anli Zhang, Casey Moore, Zhenhua Ren, Changzheng Lu, Xuezhi Cao, Chun‐Li Zhang, Jian Qiao, Yang-Xin Fu	116
9	Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling 2020 ·Nature Immunology ·Chuanhui Han, Zhida Liu, Yunjia Zhang, Aijun Shen, Chunbo Dong, Anli Zhang, Casey Moore, Zhenhua Ren, Changzheng Lu, Xuezhi Cao, Chun‐Li Zhang, Jian Qiao, Yang-Xin Fu	2
10	MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway 2020 ·Cancer Cell ·Junhong Guan, Changzheng Lu, Qihuang Jin, Huiming Lu, Xiang Chen, Lei Tian, Yanbin Zhang, Janice Ortega, Junqiu Zhang, Silvia Siteni, Mingyi Chen, Liya Gu, Jerry W. Shay, Anthony J. Davis, Zhijian J. Chen, Yang‐Xin Fu, Guo‐Min Li	161
11	Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity 2019 ·Science Immunology ·Zhida Liu, Chuanhui Han, Chunbo Dong, Aijun Shen, Eric J. Hsu, Zhenhua Ren, Changzheng Lu, Longchao Liu, Anli Zhang, (unknown), Yang Pu, Yang Wang, Mingyi Chen, Jian Qiao, Yang-Xin Fu	35
12	Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load 2018 ·Journal of Clinical Investigation ·Hao‐Dong Li, Ileana Cuevas, (unknown), Changzheng Lu, Md Maksudul Alam, Yang‐Xin Fu, Ming You, Esra A. Akbay, He Zhang, Diego H. Castrillón	55
13	Increased Differentiation Capacity of Bone Marrow-Derived Mesenchymal Stem Cells in Aquaporin-5 Deficiency 2012 ·Stem Cells and Development ·Fei Yi, (unknown), Hongwen Gao, (unknown), Meiyan Sun, Lili Zhong, Changzheng Lu, Xuechao Feng, Tonghui Ma	15
14	[Radiosensitizing effects of Lycium barbarum polysaccharide for Lewis lung cancer]. 1991 ·PubMed ·Changzheng Lu, Bolin Cheng	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact